{"schema_version":"1.0","type":"article","title":"SpaceX 上太空，錢在晶體裡？微重力製藥的第一桶金","url":"https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals.html","markdown_url":"https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals.md","lang":"zh-Hant","date":"2026-07-24","publish_at":"2026-07-24T16:20:00+08:00","updated_at":"2026-07-24","category":"商業分析系列","topic":"商業分析系列","tags":["SpaceX","微重力","太空製藥","藥物結晶","Keytruda","Redwire","SpaceMD","Varda","製劑開發","台灣生技"],"summary":"SpaceX 讓低軌往返逐漸有了班次，但火箭不是新藥公司。本文從 Keytruda 結晶、SpaceMD、Varda、英國監管與台灣任務，拆解微重力製藥能否通過重複、放大與監管三道商業考驗。","key_points":[],"facts":[],"sections":["01｜SpaceX 把軌道變成可以反覆往返的實驗室","02｜Keytruda 的太空旅程，留下了一堂製劑物理課","03｜同一片軌道，長出了三種生意","04｜太空附加值，要過四道商業關卡","05｜台灣把蛋白質結晶實驗送上了太空","06｜2030 前後，軌道實驗空間也會被重新定價","結語｜下一個製劑答案，可能先繞一趟太空","參考資料","免責聲明"],"references":[{"title":"[Redwire／SpaceMD]","source":"","date":"","url":"https://ir.rdw.com/news-events/press-releases/detail/235/former-merck-and-nasa-leaders-bring-strategic-expertise-to"},{"title":"[NASA／SpaceX CRS-34]","source":"","date":"","url":"https://www.nasa.gov/missions/station/iss-research/nasas-spacex-crs-34-dragon-returns-packed-with-space-station-science/"},{"title":"[NASA／2026-06-17 Dragon 濺落紀錄]","source":"","date":"","url":"https://www.nasa.gov/blogs/spacestation/2026/06/17/spacex-dragon-splashes-down-in-pacific-completes-cargo-mission/"},{"title":"[npj Microgravity／Pembrolizumab microgravity crystallization experimentation]","source":"","date":"","url":"https://www.nature.com/articles/s41526-019-0090-3"},{"title":"[NASA／Space Station Research Informs New FDA-Approved Cancer Therapy]","source":"","date":"","url":"https://www.nasa.gov/missions/station/iss-research/space-station-research-informs-new-fda-approved-cancer-therapy/"},{"title":"[FDA／Keytruda Qlex]","source":"","date":"","url":"https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-subcutaneous-injection"},{"title":"[Varda Space Industries／任務頁]","source":"","date":"","url":"https://www.varda.com/platform"},{"title":"[npj Microgravity／Varda ritonavir Form III]","source":"","date":"","url":"https://www.nature.com/articles/s41526-026-00594-0"},{"title":"[英國政府／太空製藥監管路線]","source":"","date":"","url":"https://www.gov.uk/government/news/uk-sets-out-world-leading-pathway-for-space-manufactured-drugs"},{"title":"[Space BD／NSRRC 太空蛋白質結晶]","source":"","date":"","url":"https://www.space-bd.com/dam/include-content/PUBLIC/en/news_archive/storage/news20220303-001/pdf/20220520en-4.pdf"},{"title":"[HelioX Cosmos]","source":"","date":"","url":"https://www.helioxcosmos.com/about/ABOUT-US/"},{"title":"[中國科學院上海藥物研究所]","source":"","date":"","url":"https://simm.cas.cn/web/xwzx/kydt/202508/t20250801_7900455.html"},{"title":"[Chinese Academy of Sciences／SIMM English release]","source":"","date":"","url":"https://english.simm.cas.cn/News/Headline/202508/t20250829_1051693.html"},{"title":"[NASA／Commercial Space Stations]","source":"","date":"","url":"https://www.nasa.gov/humans-in-space/commercial-space/commercial-space-stations/"},{"title":"[MHRA／The Next Frontier: unlocking in-orbit manufacturing of medicines]","source":"","date":"","url":"https://medregs.blog.gov.uk/2026/06/25/the-next-frontier-unlocking-in-orbit-manufacturing-of-medicines/"},{"title":"[UK Space Agency／Annual Report 2025–2026]","source":"","date":"","url":"https://www.gov.uk/government/publications/uk-space-agency-annual-report-and-accounts-2025-2026/uk-space-agency-annual-report-2025-2026"}],"images":[{"alt":"SpaceX 把候選分子送上太空，再把晶體樣本帶回地球","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals/01_SpaceX_%E6%8A%8A%E8%97%A5%E9%80%81%E4%B8%8A%E5%A4%AA%E7%A9%BA_GPT.webp"},{"alt":"地球重力與微重力下的晶體生長差異","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals/02_%E5%9C%B0%E7%90%83%E8%88%87%E5%BE%AE%E9%87%8D%E5%8A%9B%E6%99%B6%E9%AB%94_GPT.webp"},{"alt":"太空製藥的最小可行價值鏈","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals/03_%E5%A4%AA%E7%A9%BA%E8%A3%BD%E8%97%A5%E5%83%B9%E5%80%BC%E9%8F%88_GPT.webp"},{"alt":"台灣太空結晶能力座標","url":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals/04_%E5%8F%B0%E7%81%A3%E5%A4%AA%E7%A9%BA%E7%B5%90%E6%99%B6%E5%BA%A7%E6%A8%99_GPT.webp"}],"cover_image":"https://drugnews.com.tw/assets/articles/spacex-microgravity-drug-crystals/cover-zh.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-07-24）。SpaceX 上太空，錢在晶體裡？微重力製藥的第一桶金。https://drugnews.com.tw/articles/2026-07-24-spacex-microgravity-drug-crystals.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-07-24-spacex-microgravity-drug-crystals-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}